DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹794 Cr | ₹715 Cr | ₹1,509 Cr | ₹761 Cr | ₹1,150 Cr |
What is the latest Short Term Loans and Advances ratio of DIVIS LABORATORIES ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹794 Cr |
Mar2023 | ₹715 Cr |
Mar2022 | ₹1,509 Cr |
Mar2021 | ₹761 Cr |
Mar2020 | ₹1,150 Cr |
How is Short Term Loans and Advances of DIVIS LABORATORIES Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹794 Cr | 11.05 | |
Mar2023 | ₹715 Cr | -52.63 | |
Mar2022 | ₹1,509 Cr | 98.37 | |
Mar2021 | ₹761 Cr | -33.85 | |
Mar2020 | ₹1,150 Cr | - |
Compare Short Term Loans and Advances of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹181,418.8 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
MANKIND PHARMA | ₹106,401.0 Cr | 6.8% | 8% | 20.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | -0.7% |
1.6% |
50.2% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses